A549-Dual™ KO-RIG-I Cells

A549-Dual™ KO-RIG-I cells were generated from A549-Dual™ cells through the stable knockout of the RIG-I gene. They are adherent epithelial cells derived from the human A549 lung carcinoma cell line by stable integration of two inducible reporter constructs. The A549 cell line, a cellular model for asthma and respiratory infections, expresses many pattern recognition receptors (PRRs), including RIG-I [1, 2], and the Toll-like receptors (TLRs) TLR2 [3], TLR3 and TLR5 but not TLR4 [3].

A549-Dual™ KO-RIG-I and A549-Dual™ cells express a secreted embryonic alkaline phosphatase (SEAP) reporter gene under the control of the IFN-β minimal promoter fused to five NF-κB binding sites. They also express the secreted Lucia luciferase reporter gene under the control of an ISG54 minimal promoter in conjunction with five IFN-stimulated response elements. As a result, they allow to simultaneously study the NF-kB pathway, by assessing the activity of SEAP, and the interferon regulatory factor (IRF) pathway, by monitoring the activity of Lucia luciferase. Both reporter proteins are readily measurable in the cell culture supernatant when using QUANTI- Blue™, a SEAP detection reagent, and QUANTI‑Luc™, a Lucia luciferase detection reagent.

A549-Dual™ KO-RIG-I cells are resistant to blasticidin and Zeocin™.

Figures for this product

Figure 1: IRF INDUCTION (Lucia luciferase reporter)Figure 2: NF-kB INDUCTION (SEAP reporter)


Antibiotic resistance: Zeocin™blasticidin

Growth Medium: DMEM, 4.5 g/l glucose, 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™, 2 mM L-glutamine.

Test Medium for use with QUANTI-Blue™: DMEM, 2 mM L-glutamine, 4.5 g/l glucose, 10% (v/v) heat-inactivated FBS (30 min at 56°C), 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™ 

Quality control
• RIG-I knockout has been verified by functional assays and DNA sequencing.
• The stability of this cell line for 20 passages following thawing has been verified.
• A549-DualKO-RIG-I cells are guaranteed mycoplasma-free.

Shipped on dry ice

This product is covered by a Limited Use License (See Terms and Conditions).


1 vial containing 3-7 x 106 cells

100 μl Zeocin™ (100 mg/ml)

100 μl blasticidin (10 mg/ml)

1 ml Normocin™ (50 mg/ml)

1 pouch of QUANTI-Blue™ (SEAP detection medium)

1 pouch of QUANTI-Luc™.

Shipped on dry ice


A549-Dual KO-RIG-I pathway

RIG-I (retinoic-acid-inducible protein 1, also known as Ddx58) is a cytoplasmic RNA helicase that is critical for host antiviral responses. It senses double-stranded RNA (dsRNA), a replication intermediate for RNA viruses, leading to production of type I interferons (IFNs). Notably, it binds specifically to short dsRNAs that have blunt ends and a 5′ triphosphate (5′-ppp) moiety, facilitating discrimination between host and viral dsRNA. RIG-I and the related RNA helicase MDA-5 recognize a complementary set of cytosolic viral dsRNA. Interestingly, transfected poly(I:C), a synthetic analog of viral dsRNA, is recognized by both RIG-I and MDA-5.


  1. Kolokoltsova OA. et al., 2014. RIG-I enhanced interferon independent apoptosis upon Junin virus infection. PLoS One. 9:e99610.
  2. Hagmann CA. et al., 2013. RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells. PLoS One. 8:e62872.
  3. Slevogt H. et al., 2007. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell Microbiol. 9(3):694-707.


A549-Dual™ KO-RIG-I cells

Description RIG-I knockout NF-kB-SEAP & IRF-Lucia reporter lung carcinoma cells
Cat. Codea549d-korigi
Unit Size3-7 x 10e6 cells
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".